• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMINISTRATION, INFUSION Back to Search Results
Model Number 2420-0007
Device Problems Excess Flow or Over-Infusion (1311); Use of Device Problem (1670); Improper Flow or Infusion (2954); Appropriate Term/Code Not Available (3191)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/17/2019
Event Type  malfunction  
Manufacturer Narrative
Product support.Although requested, device has not been received, and patient demographic details were not provided.A follow up report will be submitted with failure investigation results should the device be received for evaluation.(b)(4).
 
Event Description
It was reported that the user observed that an over infusion of blinatumomab had occurred when the user changed the medication bag.The total volume of bag was 278ml, and the volume to be infused programmed on the pump was 240ml.The patient received an extra volume of medication more than prescriber¿s order.No patient harm occurred as a result of the event.The biomed investigation determined that the pump module tested within specification, and 19 ail alarms had occurred in the logs.A micro crack on the bezel was identified but did not contribute to the event.The user opened the door 8 times to clear the alarm, and entries for ¿flow stop open¿ were observed.During chemotherapy infusions it is expected hospital practice to avoid accessing the line with a syringe.Biomed indicated that during troubleshooting ail, it is believed that more fluid may have flowed than the user expected.
 
Manufacturer Narrative
Additional event details provided.
 
Event Description
It was reported that the user observed that an over infusion of a 24 hour primary infusion of blinatumomab had occurred when the user changed the medication bag.The total volume of bag was 278ml, and the volume to be infused programmed on the pump was 240ml; it was expected there would be 38ml left in the bag at the time of the bag change.The tubing priming volume was accounted for.The patient received an extra volume of medication more than prescriber¿s order.No patient harm occurred as a result of the event.The biomed investigation determined that the pump module tested within specification, and 19 ail alarms had occurred in the logs.A micro crack on the bezel was identified but did not contribute to the event.The user opened the door 8 times to clear the alarm, and entries for ¿flow stop open¿ were observed.During chemotherapy infusions it is expected hospital practice to avoid accessing the line with a syringe.Biomed indicated that during troubleshooting ail, it is believed that more fluid may have flowed than the user expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMINISTRATION, INFUSION
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8611902
MDR Text Key145110998
Report Number9616066-2019-01364
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public7613203021012
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/24/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2420-0007
Device Catalogue Number2420-0007
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/15/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8100,8015, THERAPY DATE (B)(6) 2019; 8100,8015, THERAPY DATE (B)(6) 2019
-
-